Pfizer Slow-Plays Results Of COVID Vax Trial In Pregnant Women
View Source | February 23, 2023 5:40 pm
Continue to Article
- When covid-19 vaccines were granted emergency authorization in Dec 2020, there was consternation over whether pregnant women should be vaccinated.
- In the absence of any human data, Pfizer announced it would begin recruiting volunteers for a clinical trial to examine the safety and efficacy of its mRNA vaccine in pregnant women and their newborns.
- The trial, which began in February 2021, originally intended to enroll 4,000 women, but enrollment stopped in late 2021 with just 349 participants.
Share This Article: